Cargando…

Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer

Radioactive iodine (RAI) plays an important role in the diagnosis and treatment of papillary thyroid cancer (PTC). The curative effects of RAI therapy are not only related to radiosensitivity but also closely related to the accumulation of radionuclides in the lesion in PTC. Sinomenine hydrochloride...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Zhao, Aomei, Jia, Xi, Li, Xinru, Liang, Yiqian, Liu, Yan, Xie, Xin, Qu, Xijie, Wang, Qi, Zhang, Yuemin, Gao, Rui, Yu, Yan, Yang, Aimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500915/ https://www.ncbi.nlm.nih.gov/pubmed/36142613 http://dx.doi.org/10.3390/ijms231810709

Ejemplares similares

Synergic radiosensitization of sinomenine hydrochloride and radioiodine on human papillary thyroid carcinoma cells
por: Zhao, Aomei, et al.
Publicado: (2021)

Agranulocytosis Induced by Sinomenine Hydrochloride
por: Chen, Juerong, et al.
Publicado: (2017)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma
por: Zhou, Changxin, et al.
Publicado: (2019)

Sinomenine Hydrochloride Protects against Polymicrobial Sepsis via Autophagy
por: Jiang, Yu, et al.
Publicado: (2015)

Sinomenine hydrochloride inhibits cell survival in human hepatoma Huh7 cells
por: Wang, Ying, et al.
Publicado: (2018)

Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells
por: Fu, Shenbo, et al.
Publicado: (2018)

Vascular Normalization Induced by Sinomenine Hydrochloride Results in Suppressed Mammary Tumor Growth and Metastasis
por: Zhang, Huimin, et al.
Publicado: (2015)

Exploratory study data for determining the adverse effects of sinomenine plus gabapentin or ligustrazine hydrochloride and the pharmacokinetic insights of sinomenine in plasma and CNS tissue
por: Gao, Tianle, et al.
Publicado: (2019)

The Role of TSHR, PTEN and RASSF1A Promoters’ Methylation Status for Non-Invasive Detection of Papillary Thyroid Carcinoma
por: Klimaitė, Raimonda, et al.
Publicado: (2022)

New Molecular Targeted Therapy and Redifferentiation Therapy for Radioiodine-Refractory Advanced Papillary Thyroid Carcinoma: Literature Review
por: Wong, Kai-Pun, et al.
Publicado: (2012)

Sinomenine Hydrochloride Attenuates Renal Fibrosis by Inhibiting Excessive Autophagy Induced by Adriamycin: An Experimental Study
por: Zhao, Ming-ming, et al.
Publicado: (2017)

Regulation of TSHR Expression in the Thyroid and Thymus May Contribute to TSHR Tolerance Failure in Graves' Disease Patients via Two Distinct Mechanisms
por: Marín-Sánchez, Ana, et al.
Publicado: (2019)

Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia
por: Xue, Jianjun, et al.
Publicado: (2018)

Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer
por: Larson, Steven M., et al.
Publicado: (2017)

Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications
por: Gao, Rui, et al.
Publicado: (2019)

Sinomenine hydrochloride sensitizes cervical cancer cells to ionizing radiation by impairing DNA damage response
por: Zhang, Dan, et al.
Publicado: (2018)

HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E
por: Cheng, Lingxiao, et al.
Publicado: (2017)

Sinomenine hydrochloride injection for knee osteoarthritis: A protocol for systematic review and meta-analysis
por: Huang, Zeling, et al.
Publicado: (2022)

Antiproliferation and Redifferentiation in Thyroid Cancer Cell Lines by Polyphenol Phytochemicals
por: Kang, Hee Joon, et al.
Publicado: (2011)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
por: Jafri, Sabih, et al.
Publicado: (2021)

Strategies to Modulate the Redifferentiation of Chondrocytes
por: Hu, Xiaoshen, et al.
Publicado: (2021)

Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome
por: Song, Hui, et al.
Publicado: (2019)

TSH-TSHR axis promotes tumor immune evasion
por: Wu, Zhenghao, et al.
Publicado: (2022)

Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material
por: Kartal, Kinyas, et al.
Publicado: (2015)

Controlled release of optimized electroporation enhances the transdermal efficiency of sinomenine hydrochloride for treating arthritis in vitro and in clinic
por: Feng, Shun, et al.
Publicado: (2017)

Polyvinylpyrrolidone microneedles for localized delivery of sinomenine hydrochloride: preparation, release behavior of in vitro & in vivo, and penetration mechanism
por: Shu, Zixuan, et al.
Publicado: (2020)

Comparative Pharmacokinetics Study of Sinomenine in Rats after Oral Administration of Sinomenine Monomer and Sinomenium Acutum Extract
por: Zhang, Mao-Fan, et al.
Publicado: (2014)

MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF(V600E): An In Vitro Study
por: Fu, Hao, et al.
Publicado: (2019)

Letter to the Editor: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals
por: Kim, Tae Yong
Publicado: (2011)

The Author Response: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals
por: Kang, Hee Joon, et al.
Publicado: (2011)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer
por: Choi, Yoon Ju, et al.
Publicado: (2021)

Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness
por: Li, Xiao, et al.
Publicado: (2017)

Sinomenine Hydrochloride Can Ameliorate Benign Prostatic Hyperplasia by Lowering the 5α-Reductase 2 Level and Regulating the Balance between the Proliferation and Apoptosis of Cells
por: Fan, Mao-Si, et al.
Publicado: (2023)

Fibroblast rejuvenation by mechanical reprogramming and redifferentiation
por: Roy, Bibhas, et al.
Publicado: (2020)

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
por: Aashiq, Mohamed, et al.
Publicado: (2019)

MAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: an in vitro and in vivo study
por: Li, X, et al.
Publicado: (2014)

Sinomenine hydrochloride ameliorates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota composition whilst suppressing the activation of the NLRP3 inflammasome
por: Zhou, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h9vbjc6spda5n9g63ujflk3lg4